Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol

PaperCitations, authors & open-access status

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 694 citations, 2016 year and hybrid oa status.

694
Citations
2016
Year
hybrid
OA Status

Related on ScholarIQ

Morten Wang Fagerland
Author
Pavel Hoffmann
Author
Jeanette Schulz‐Menger
Author
European Heart Journal
Journal
Chemotherapy-induced cardiotoxicity and mitigation
Topic
Chemotherapy-induced cardiotoxicity and mitigation
Topic
470M+ articles · free account